Japan
# |
Name |
Net Income |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 2.31 B
|
Dec. 31, 2023 | USD 43.39 | 5.16% |
|
Japan |
|
2 |
USD 1.60 B
|
March 31, 2024 | USD 15.25 | -1.27% |
|
Japan |
|
3 |
USD 1.33 B
|
March 31, 2024 | USD 27.56 | -3.63% |
|
Japan |
|
4 |
USD 1.07 B
|
March 31, 2024 | USD 14.75 | -0.46% |
|
Japan |
|
5 |
USD 951.85 M
|
March 31, 2024 | USD 27.12 | 0.10% |
|
Japan |
|
6 |
USD 845.54 M
|
March 31, 2024 | USD 10.39 | -0.80% |
|
Japan |
|
7 |
USD 702.81 M
|
March 31, 2024 | USD 18.88 | -4.20% |
|
Japan |
|
8 |
USD 575.38 M
|
Dec. 31, 2023 | USD 14.95 | -1.71% |
|
Japan |
|
9 |
USD 376.84 M
|
March 31, 2024 | USD 29.12 | 0.44% |
|
Japan |
|
10 |
USD 345.86 M
|
March 31, 2024 | USD 14.83 | -0.95% |
|
Japan |
|
11 |
USD 334.81 M
|
March 31, 2024 | USD 20.12 | -0.87% |
|
Japan |
|
12 |
USD 327.96 M
|
March 31, 2024 | USD 19.21 | -1.38% |
|
Japan |
|
13 |
USD 299.11 M
|
March 31, 2024 | USD 9.15 | -1.97% |
|
Japan |
|
14 |
USD 280.18 M
|
March 31, 2024 | USD 29.77 | -0.89% |
|
Japan |
|
15 |
USD 274.02 M
|
March 31, 2024 | USD 15.05 | -0.63% |
|
Japan |
|
16 |
USD 195.29 M
|
March 31, 2024 | USD 13.71 | -0.73% |
|
Japan |
|
17 |
USD 192.44 M
|
March 31, 2024 | USD 27.09 | -1.08% |
|
Japan |
|
18 |
USD 191.71 M
|
March 31, 2024 | USD 31.25 | -0.69% |
|
Japan |
|
19 |
USD 176.32 M
|
Feb. 29, 2024 | USD 14.39 | -0.85% |
|
Japan |
|
20 |
USD 170.80 M
|
March 31, 2024 | USD 24.26 | -0.77% |
|
Japan |
|
21 |
USD 155.43 M
|
May 31, 2024 | USD 46.78 | -2.70% |
|
Japan |
|
22 |
USD 153.21 M
|
May 31, 2024 | USD 61.25 | 0.14% |
|
Japan |
|
23 |
USD 146.51 M
|
Feb. 29, 2024 | USD 17.40 | -0.57% |
|
Japan |
|
24 |
USD 136.48 M
|
March 31, 2024 | USD 27.69 | -1.34% |
|
Japan |
|
25 |
USD 123.50 M
|
March 31, 2024 | USD 43.36 | -1.17% |
|
Japan |
|
26 |
USD 112.62 M
|
March 31, 2024 | USD 9.76 | -1.53% |
|
Japan |
|
27 |
USD 112.49 M
|
March 31, 2024 | USD 14.30 | -1.12% |
|
Japan |
|
28 |
USD 110.38 M
|
March 31, 2024 | USD 29.51 | -0.48% |
|
Japan |
|
29 |
USD 106.86 M
|
March 31, 2024 | USD 19.43 | -1.89% |
|
Japan |
|
30 |
USD 98.42 M
|
June 30, 2024 | USD 16.87 | -2.21% |
|
Japan |
|
31 |
USD 93.12 M
|
Feb. 29, 2024 | USD 28.70 | -1.67% |
|
Japan |
|
32 |
USD 91.10 M
|
March 31, 2024 | USD 13.67 | -2.04% |
|
Japan |
|
33 |
USD 90.48 M
|
March 31, 2024 | USD 12.96 | -0.41% |
|
Japan |
|
34 |
USD 78.22 M
|
May 31, 2024 | USD 21.33 | 0.54% |
|
Japan |
|
35 |
USD 73.73 M
|
March 31, 2024 | USD 25.51 | -0.96% |
|
Japan |
|
36 |
USD 73.40 M
|
March 31, 2024 | USD 9.35 | -1.03% |
|
Japan |
|
37 |
USD 72.24 M
|
April 30, 2024 | USD 30.20 | 0.44% |
|
Japan |
|
38 |
USD 57.36 M
|
Dec. 31, 2023 | USD 21.58 | 0.31% |
|
Japan |
|
39 |
USD 53.02 M
|
March 31, 2024 | USD 27.19 | -2.00% |
|
Japan |
|
40 |
USD 51.08 M
|
March 31, 2024 | USD 14.41 | -0.72% |
|
Japan |
|
41 |
USD 49.65 M
|
March 31, 2024 | USD 9.19 | -0.31% |
|
Japan |
|
42 |
USD 47.75 M
|
March 31, 2024 | USD 10.75 | -2.71% |
|
Japan |
|
43 |
USD 42.99 M
|
Aug. 31, 2024 | USD 9.32 | -2.24% |
|
Japan |
|
44 |
USD 42.76 M
|
Sept. 30, 2024 | USD 9.46 | -2.05% |
|
Japan |
|
45 |
USD 39.37 M
|
June 30, 2024 | USD 20.26 | -6.39% |
|
Japan |
|
46 |
USD 38.60 M
|
March 31, 2024 | USD 7.64 | -1.09% |
|
Japan |
|
47 |
USD 36.55 M
|
March 31, 2024 | USD 10.95 | -0.53% |
|
Japan |
|
48 |
USD 36.38 M
|
March 31, 2024 | USD 3.56 | -3.55% |
|
Japan |
|
49 |
USD 35.16 M
|
March 31, 2024 | USD 9.48 | -0.72% |
|
Japan |
|
50 |
USD 35.03 M
|
Oct. 31, 2024 | USD 76.41 | -0.92% |
|
Japan |
The Healthcare company in Japan with the highest Net Income is Chugai Pharmaceutical Co., Ltd. (Tokyo Stock Exchange: 4519.T) at USD 2.31 B.
The Healthcare company in Japan with the lowest Net Income is PHC Holdings Corporation (Tokyo Stock Exchange: 6523.T) at USD -85.18 M.
The top 10 Healthcare companies in Japan by Net Income are Chugai Pharmaceutical Co., Ltd., Olympus Corporation, Daiichi Sankyo Company, Limited, Shionogi & Co., Ltd., Takeda Pharmaceutical Company Limited, Ono Pharmaceutical Co., Ltd., Terumo Corporation, Kyowa Kirin Co., Ltd., Shimadzu Corporation and MatsukiyoCocokara & Co..
The bottom 10 Healthcare companies in Japan by Net Income are PHC Holdings Corporation, Nxera Pharma Co., Ltd., SanBio Company Limited, SymBio Pharmaceuticals Limited, Oncolys BioPharma Inc., StemRIM, MEDINET Co., Ltd., OncoTherapy Science, Inc., Carna Biosciences, Inc. and Solasia Pharma K.K..